| http://www.w3.org/ns/prov#value | - The judge, quoting a law review article by former FDA Commissioner, David Kessler, stated: The most fundamental problem is that drugs are approved on the basis of clinical testing that cannot, and is not designed to, uncover risks that are relatively rare or have long latency periods.
|
